Pepcura Pharmaceuticals Private Limited
About Pepcura Pharmaceuticals Private Limited
Data last updated:
Pepcura Pharmaceuticals Private Limited is a private limited company based in Raipur, Chhattisgarh, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 26 September 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Chhattisgarh, under CIN U74999CT2016PTC007555. Its GSTIN is 20AAICP7965J1Z2 (Jharkhand).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹4.21 Lakh. It is led by directors Sunil Kumar Dangaich and Saniya Dangaich.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at E 412 Samta Colony Back Road Of Dr Goyal Nursing Home, Raipur, Chhattisgarh, India – 492001.
As per the financials filed for FY 2025, the company reported a revenue of ₹51.12 Lakh, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹49,908 (net margin 1%) and EBITDA of ₹2.69 Lakh (EBITDA margin 5.3%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years and 7% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Pepcura Pharmaceuticals Private Limited's registered office is in Raipur, Chhattisgarh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressE 412 Samta Colony Back Road Of Dr Goyal Nursing Home, Raipur, Chhattisgarh, India – 492001
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Pepcura Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Pepcura Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Pepcura Pharmaceuticals Private Limited, buy the company report.
Financials of Pepcura Pharmaceuticals Private Limited
FY 2025 filings availablePepcura Pharmaceuticals Private Limited reported revenue of ₹51.12 Lakh (up 4% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 4% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 7%. EBITDA rose 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.69 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹49,908 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.3% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Pepcura Pharmaceuticals Private Limited, buy the company report.
Board of directors of Pepcura Pharmaceuticals Private Limited
Pepcura Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sunil Kumar Dangaich | Director | 26 Sep 2016 | 10 Years 1 Months | Current |
| Saniya Dangaich | Director | 08 Dec 2024 | 1 Years 11 Months | Current |
Auditor
Pepcura Pharmaceuticals Private Limited is audited by KEDIA AGARWAL & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KEDIA AGARWAL & ASSOCIATES | FY 2017 | 316089E |
Shareholding
The shareholding of Pepcura Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Pepcura Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Pepcura Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Pepcura Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Pepcura Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 20AAICP7965J1Z2 | Jharkhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Pepcura Pharmaceuticals Private Limited, buy the company report.
Recent activity
Pepcura Pharmaceuticals Private Limited has 3 board changes on record since 2016: 2 appointments and 1 cessation. The latest: Saniya Dangaich was appointed as Director on 08 Dec 2024.
Frequently asked questions
Pepcura Pharmaceuticals is an active private limited company based in Raipur, Chhattisgarh, India. The company works in other services, within the business services industry. It was incorporated on 26 September 2016 (10+ years old) and is registered under CIN U74999CT2016PTC007555.
Pepcura Pharmaceuticals has 2 current directors:
- Sunil Kumar Dangaich - Director
- Saniya Dangaich - Director
The latest financial statements of Pepcura Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Pepcura Pharmaceuticals is 20AAICP7965J1Z2, registered in Jharkhand.
The CIN (Corporate Identification Number) of Pepcura Pharmaceuticals is U74999CT2016PTC007555. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pepcura Pharmaceuticals was incorporated on 26 September 2016, making it 10+ years old. It is registered with the Registrar of Companies, Chhattisgarh.
Saniya Dangaich was appointed as Director on 08 Dec 2024. Venu Dangaich ceased to be Director on 08 Dec 2024. Sunil Kumar Dangaich was appointed as Director on 26 Sep 2016.
The registered office of Pepcura Pharmaceuticals is at E 412 Samta Colony Back Road Of Dr Goyal Nursing Home, Raipur, Chhattisgarh, India – 492001.
Pepcura Pharmaceuticals operates in the business services industry, in the other services segment.
The compliance status of Pepcura Pharmaceuticals is compliant as of 15 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
